EUR 23.85
(-0.63%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 | 647.06 Million EUR | -1.52% |
2023 | 657.08 Million EUR | 3.88% |
2022 | 632.55 Million EUR | 11.15% |
2021 | 569.11 Million EUR | 12.47% |
2020 | 505.99 Million EUR | 27.89% |
2019 | 395.66 Million EUR | 3.06% |
2018 | 383.9 Million EUR | 48.95% |
2017 | 257.73 Million EUR | 36.74% |
2016 | 188.49 Million EUR | 17.97% |
2015 | 159.77 Million EUR | 16.37% |
2014 | 137.29 Million EUR | 19.37% |
2013 | 115.01 Million EUR | 10.36% |
2012 | 104.22 Million EUR | 8.12% |
2011 | 96.39 Million EUR | 15.46% |
2010 | 83.48 Million EUR | 5.33% |
2009 | 79.26 Million EUR | 7.57% |
2008 | 73.68 Million EUR | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q4 | 647.06 Million EUR | 0.0% |
2024 Q2 | 659.36 Million EUR | 0.0% |
2023 Q4 | 657.08 Million EUR | 0.0% |
2023 Q2 | 656.4 Million EUR | 0.0% |
2023 FY | 657.08 Million EUR | 3.88% |
2022 Q2 | 600.71 Million EUR | 0.0% |
2022 FY | 632.55 Million EUR | 11.15% |
2022 Q4 | 632.55 Million EUR | 0.0% |
2021 Q2 | 560.97 Million EUR | 0.0% |
2021 FY | 569.11 Million EUR | 12.47% |
2021 Q4 | 569.11 Million EUR | 0.0% |
2020 Q2 | 474.09 Million EUR | 0.0% |
2020 Q4 | 505.99 Million EUR | 0.0% |
2020 FY | 505.99 Million EUR | 27.89% |
2019 FY | 395.66 Million EUR | 3.06% |
2019 Q2 | 385.82 Million EUR | 0.0% |
2019 Q4 | 395.66 Million EUR | 0.0% |
2018 Q4 | 383.9 Million EUR | 0.0% |
2018 FY | 383.9 Million EUR | 48.95% |
2018 Q2 | 336.52 Million EUR | 0.0% |
2017 Q4 | 257.73 Million EUR | 0.0% |
2017 Q2 | 239.26 Million EUR | 0.0% |
2017 FY | 257.73 Million EUR | 36.74% |
2016 Q2 | 169.13 Million EUR | 0.0% |
2016 Q4 | 188.49 Million EUR | 0.0% |
2016 FY | 188.49 Million EUR | 17.97% |
2015 FY | 159.77 Million EUR | 16.37% |
2015 Q2 | 153.72 Million EUR | 0.0% |
2015 Q4 | 159.77 Million EUR | 0.0% |
2014 FY | 137.29 Million EUR | 19.37% |
2014 Q4 | 137.29 Million EUR | 0.0% |
2014 Q2 | 131.27 Million EUR | 0.0% |
2013 Q4 | 115.01 Million EUR | 0.0% |
2013 FY | 115.01 Million EUR | 10.36% |
2013 Q2 | 110.4 Million EUR | 0.0% |
2012 Q4 | 104.22 Million EUR | 0.0% |
2012 FY | 104.22 Million EUR | 8.12% |
2012 Q2 | 103.62 Million EUR | 0.0% |
2012 Q3 | 104.22 Million EUR | 0.58% |
2011 FY | 96.39 Million EUR | 15.46% |
2011 Q2 | 88.03 Million EUR | 0.0% |
2011 Q4 | 96.39 Million EUR | 0.0% |
2010 FY | 83.48 Million EUR | 5.33% |
2010 Q2 | 82.26 Million EUR | 0.0% |
2010 Q4 | 83.48 Million EUR | 0.0% |
2009 Q4 | 79.26 Million EUR | 0.0% |
2009 FY | 79.26 Million EUR | 7.57% |
2008 FY | 73.68 Million EUR | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Cegedim SA | 924.06 Million EUR | 29.976% |
Guerbet SA | 1.02 Billion EUR | 36.886% |
Nexus AG | 411.71 Million EUR | -57.163% |
Revenio Group Oyj | 137.4 Million EUR | -370.937% |
Drägerwerk AG & Co. KGaA | 3.25 Billion EUR | 80.129% |
Sartorius Aktiengesellschaft | 9.75 Billion EUR | 93.367% |
LNA Santé SA | 1.5 Billion EUR | 57.066% |
Siemens Healthineers AG | 46.68 Billion EUR | 98.614% |
Medios AG | 594.75 Million EUR | -8.796% |
Equasens Société anonyme | 394.04 Million EUR | -64.211% |
Stratec SE | 479.53 Million EUR | -34.937% |